Carbapenem-hydrolyzing oxacillinase, OXA-48, persists in Klebsiella pneumoniae in Istanbul, Turkey

Chemotherapy

Volumn 54, Issue 2, 2008, Pages 101-106

  Aktaş, Zerrin ^a   Kayacan, Çiǧdem Bal ^a   Schneider, Ines ^c   Can, Bariş ^a   Midilli, Kenan ^b   Bauernfeind, Adolf ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c MICOER Institute   (Germany)

Author keywords

Carbapenemase; Klebsiella pneumoniae; OXA 48; Oxacillinase

Indexed keywords

AMIKACIN; BETA LACTAMASE; BETA LACTAMASE AMPC; CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; OXACILLINASE 48; PIPERACILLIN; SULPERAZON; TAZOBACTAM; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BIOASSAY; CULTURE MEDIUM; ENZYME ACTIVITY; EPSILOMETER TEST; HYDROLYSIS; ISOELECTRIC FOCUSING; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; SEQUENCE ANALYSIS; TURKEY (REPUBLIC);

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; HUMANS; HYDROLYSIS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; TURKEY;

EID: 41349097999     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000118661     Document Type: Article

References (31)

1. Livermore DM, Woodford N: The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol 2006;14:13-20.
2. Bradford PA: Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14:933-951.
3. Afzal-Shah M, Woodford N, Livermore DM: Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 2001;45:583-588.
4. Bou G, Oliver A, Martinez-Beltran J: OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob Agents Chemother 2000;44:1556-1561.
5. Héritier C, Poirel L, Aubert D, Nordmann P: Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii. Antimicrob Agents Chemother 2003;47:268-273.
6. Marque S, Poirel L, Héritier C, Brisse S, Blasco MD, Filip R, Coman G, Naas T, Nordmann P: Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. J Clin Microbiol 2005;43:4885-4888.
7. Bonnet R, Marchandin H, Chanal C, Sirot D, Labia R, De Champs C, Jumas-Bilak E, Sirot J: Chromosome-encoded class D beta-lactamase OXA-23 in Proteus mirabilis. Antimicrob Agents Chemother 2002;46:2004-2006.
8. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SGB, Livermore DM: Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006;27:351-353.
9. Naas T, Levy M, Hirschaver C, Marchandin H, Nordmann P: Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia. J Clin Microbiol 2005;43:4826-4829.
10. Poirel L, Nordmann P: Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006;12:826-836.
11. Poirel L, Héritier C, Tolun V, Nordmann P: Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004;48:15-22.
12. Nazic H, Poirel L, Nordmann P: Further identification of plasmid-mediated quinolone resistance determinant in Enterobacteriaceae in Turkey. Antimicrob Agents Chemother 2005;49:2146-2147.
13. Poirel L, Héritier C, Nordmann P: Chromosome-encoded ambler class D beta-lactamase of Shewanella oneidensis as a progenitor of carbapenem-hydrolyzing oxacillinase. Antimicrob Agents Chemother 2004;48:348-351.
14. National Committee for Clinical Laboratory Standards: MIC testing. Supplemental Tables. Wayne, National Committee for Clinical Laboratory Standards, 2003.
15. Bauernfeind A, Grimm H, Schweighart S: A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 1990;18:294-298.
16. Matthew M, Harris A, Marshall M, Ross G: The use of analytical isoelectric focusing for detection and identification of beta-lactamases. J Gen Microbiol 1975;88:169-178.
17. Bauernfeind A, Schneider I, Jungwirth R, Sahly H, Ullmann U: A novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia. Antimicrob Agents Chemother 1999;43:1923-1931.
18. Kado CI, Liu ST: Rapid procedure for detection of large and small plasmids. J Bacteriol 1981;145:1365-1373.
19. Arakawa Y, Shibata N, Shibayama K, Kurukowa H, Yagi T, Fujiwara H, Goto M: Convenient test for screening metallo-beta-lactamase-producing Gram-negative bacteria by using thiol compounds. J Clin Microbiol 2000;38:40-43.
20. Lee K, Chong Y, Shin HB, Kim YA, Yond D, Yum JH: Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 2001;7:88-91.
21. Poirel L, Thomas I, Naas T, Karim A, Nordmann P: Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob Agents Chemother 2000;44:622-632.
22. Gniadkowski M, Schneider I, Jungwirth R, Hryniewicz W, Bauernfeind A: Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM and SHV-5-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1998;42:514-520.
23. Karim A, Poirel L, Nagarajan S, Nordmann P: Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp 1. FEMS Microbiol Lett 2001;201:237-241.
24. Aktas Z, Poirel L, Salcioglu M, Ozcan PE, Midilli K, Bal C, Ang O, Nordmann P: PER-1 and OXA-10-like beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates from intensive care unit patients in Istanbul, Turkey. Clin Microbiol Infect 2005;11:193-198.
25. Vahapoglu H, Öztürk R, Aygun G, Coskunkan F, Yaman A, Kaygusuz A, Leblebicioglu H, Balik I, Aydin K, Otkun M: Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob Agents Chemother 1997;41:2265-2269.
26. Walther-Rasmussen J, Hoiby N: OXA-type carbapenemases. J Antimicrob Chemother 2006;57:373-383.
27. Raveh D, Yinnon AM, Broide E, Rudensky B: Susceptibilities of ESBL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid. Chemotherapy 2007;53:185-189.
28. Gulay Z, Terek G, Erac B, Bal C, Gur D, Koksal I, Ozakin C, Ozinel M, Sumerkan B: High prevalence of CTX-M-type extended-spectrum beta-lactamases in members of Enterobacteriaceae in Turkey. Clin Microbiol Infect 2004;10(suppl):187.
29. Chitnis S, Chitnis V, Hemvani N, Chitnis DS: In vitro susceptibility to meropenem and other antimicrobial agents among gramnegative bacilli isolated from hospitalized patients in central India. Chemotherapy 2006;52:43-45.
30. Livermore DM, Yuan M: Antibiotic resistance and production of extended-spectrum β-lactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother 1996;38:409-424.
31. Ramphal R: Importance of adequate initial antimicrobial therapy. Chemotherapy 2005;51:171-176.